Project BioShield: What it is, why it is needed, and its accomplishments so far

Clinical Infectious Diseases

Volumn 45, Issue SUPPL. 1, 2007, Pages

  Russell, Philip K ^a  

^a Albert B Sabin Vaccine Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE; BOTULINUM ANTISERUM; BOTULINUM TOXIN; CHELATING AGENT; IMMUNOGLOBULIN; PENTETIC ACID; POTASSIUM IODIDE;

ANTHRAX; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; CHEMICAL WARFARE; DRUG INDUSTRY; GOVERNMENT; HUMAN; MARKET; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMALLPOX VIRUS; UNITED STATES;

ANTHRAX VACCINES; BIOTERRORISM; BOTULINUM ANTITOXIN; CHELATING AGENTS; DISASTER PLANNING; HUMANS; INTERINSTITUTIONAL RELATIONS; NUCLEAR WARFARE; POTASSIUM IODIDE; RESEARCH SUPPORT; SMALLPOX VACCINE; UNITED STATES; UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES;

EID: 34447118796     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/518151     Document Type: Review

References (7)

1. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Report summary: public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002; 8:225-30.
2. US Department of Health and Human Services, Food and Drug Administration. Innovation stagnation: challenge and opportunity on the critical path to new medical products. Washington, DC: US Food and Drug Administration, 2004. Available at: http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.html. Accessed 5 April 2006.
3. National Institute of Allergy and Infectious Diseases. Category A, B and C priority pathogens. Available at: http://www3.niaid.nih.gov/Biodefense/ bandc_priority.htm. Accessed 5 April 2006.
4. US Department of Health and Human Services, Office of Public Health Emergency Preparedness. Statement of organization, functions, and delegations of authority. Federal Register 2006; 71:38403-5.
5. US Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Repsonse. HHS Public Health Emergency Medical Countermeasures Enterprise strategy for chemical, biological, radiological and nuclear threats. Federal Register 2007; 72:13109-14. Available at: http://www.hhs.gov/aspr/ophemc/enterprise/strategy/strategy.html. Accessed 19 April 2007.
6. US Department of Health and Human Services, Office of Public Health Emergency Preparedness. Draft HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) strategy for chemical, biological, radiological and nuclear (CBRN) threats. Federal Register 2006; 71:53097-102. Available at: http://www.hhs.gov/aspr/ophemc/enterprise/strategy/ strategy.html. Accessed 19 April 2007.
7. Crozier D. Commission on epidemiologic survey. In: Zajtchuk R, ed. The armed forces epidemiological board: the history of the commissions. Falls Church, VA: The Borden Institute, Office of the Surgeon General, Department of the Army, 1994:209-58.